APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Musculoskeletal System Disorder Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Musculoskeletal System Disorder Drug Industry Growth and Trends Forecast to 2032

Report ID 174015070128 December 2025114 pages

Choose your research edition.

Industry ResearchMusculoskeletal System Disorder Drug Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Musculoskeletal System Disorder Drug Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Musculoskeletal System Disorder Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Musculoskeletal System Disorder Drug Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Musculoskeletal System Disorder Drug Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

According to APO Research, the global Musculoskeletal System Disorder Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Musculoskeletal System Disorder Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Musculoskeletal System Disorder Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Musculoskeletal System Disorder Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Musculoskeletal System Disorder Drug market include Sanofi, Johnson & Johnson, Novartis, Eli Lilly, Pfizer, AbbVie, Torrent Pharmaceuticals, Nippon Shinyaku and Merck & Co, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Musculoskeletal System Disorder Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Musculoskeletal System Disorder Drug market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Musculoskeletal System Disorder Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Musculoskeletal System Disorder Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Musculoskeletal System Disorder Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Musculoskeletal System Disorder Drug Market by Company

Sanofi

Johnson & Johnson

Novartis

Eli Lilly

Pfizer

AbbVie

Torrent Pharmaceuticals

Nippon Shinyaku

Merck & Co

GSK

Eisai

Cadila Healthcare

Bayer

Astellas Pharma

Asahi Kasei

Amgen

Abbott

Musculoskeletal System Disorder Drug Segment by Type

Bone Disorder

Joint Disorder

Muscle Disorder

Other

Musculoskeletal System Disorder Drug Segment by Application

Hospital & Clinic

Retail Pharmacy

Other

Musculoskeletal System Disorder Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Musculoskeletal System Disorder Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Musculoskeletal System Disorder Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Musculoskeletal System Disorder Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Musculoskeletal System Disorder Drug companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Musculoskeletal System Disorder Drug Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Musculoskeletal System Disorder Drug Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Musculoskeletal System Disorder Drug Market Share by Region (2021-2026) Table 4. Global Musculoskeletal System Disorder Drug Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Musculoskeletal System Disorder Drug Market Share by Region (2027-2032) Table 6. Global Musculoskeletal System Disorder Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Musculoskeletal System Disorder Drug Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Musculoskeletal System Disorder Drug Market Size Share by Type (2021-2026) Table 9. Global Musculoskeletal System Disorder Drug Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Musculoskeletal System Disorder Drug Market Size Share Forecasted by Type (2027-2032) Table 11. North America Musculoskeletal System Disorder Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Musculoskeletal System Disorder Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Musculoskeletal System Disorder Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Musculoskeletal System Disorder Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Musculoskeletal System Disorder Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Musculoskeletal System Disorder Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Musculoskeletal System Disorder Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Musculoskeletal System Disorder Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Musculoskeletal System Disorder Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Musculoskeletal System Disorder Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Musculoskeletal System Disorder Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Musculoskeletal System Disorder Drug Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Musculoskeletal System Disorder Drug Market Size Share by Application (2021-2026) Table 24. Global Musculoskeletal System Disorder Drug Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Musculoskeletal System Disorder Drug Market Size Share Forecasted by Application (2027-2032) Table 26. North America Musculoskeletal System Disorder Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Musculoskeletal System Disorder Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Musculoskeletal System Disorder Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Musculoskeletal System Disorder Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Musculoskeletal System Disorder Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Musculoskeletal System Disorder Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Musculoskeletal System Disorder Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Musculoskeletal System Disorder Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Musculoskeletal System Disorder Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Musculoskeletal System Disorder Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Musculoskeletal System Disorder Drug Industry Trends Table 37. Musculoskeletal System Disorder Drug Industry Drivers Table 38. Musculoskeletal System Disorder Drug Industry Opportunities and Challenges Table 39. Musculoskeletal System Disorder Drug Industry Restraints Table 40. Global Musculoskeletal System Disorder Drug Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Musculoskeletal System Disorder Drug Revenue Market Share by Company (2021-2026) Table 42. Global Musculoskeletal System Disorder Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Musculoskeletal System Disorder Drug Key Company Headquarters & Area Served Table 44. Global Musculoskeletal System Disorder Drug Company, Product Type & Application Table 45. Global Musculoskeletal System Disorder Drug Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Musculoskeletal System Disorder Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Sanofi Company Information Table 49. Sanofi Business Overview Table 50. Sanofi Musculoskeletal System Disorder Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Sanofi Musculoskeletal System Disorder Drug Product Portfolio Table 52. Sanofi Recent Development Table 53. Johnson & Johnson Company Information Table 54. Johnson & Johnson Business Overview Table 55. Johnson & Johnson Musculoskeletal System Disorder Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Johnson & Johnson Musculoskeletal System Disorder Drug Product Portfolio Table 57. Johnson & Johnson Recent Development Table 58. Novartis Company Information Table 59. Novartis Business Overview Table 60. Novartis Musculoskeletal System Disorder Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Novartis Musculoskeletal System Disorder Drug Product Portfolio Table 62. Novartis Recent Development Table 63. Eli Lilly Company Information Table 64. Eli Lilly Business Overview Table 65. Eli Lilly Musculoskeletal System Disorder Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Eli Lilly Musculoskeletal System Disorder Drug Product Portfolio Table 67. Eli Lilly Recent Development Table 68. Pfizer Company Information Table 69. Pfizer Business Overview Table 70. Pfizer Musculoskeletal System Disorder Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Pfizer Musculoskeletal System Disorder Drug Product Portfolio Table 72. Pfizer Recent Development Table 73. AbbVie Company Information Table 74. AbbVie Business Overview Table 75. AbbVie Musculoskeletal System Disorder Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. AbbVie Musculoskeletal System Disorder Drug Product Portfolio Table 77. AbbVie Recent Development Table 78. Torrent Pharmaceuticals Company Information Table 79. Torrent Pharmaceuticals Business Overview Table 80. Torrent Pharmaceuticals Musculoskeletal System Disorder Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Torrent Pharmaceuticals Musculoskeletal System Disorder Drug Product Portfolio Table 82. Torrent Pharmaceuticals Recent Development Table 83. Nippon Shinyaku Company Information Table 84. Nippon Shinyaku Business Overview Table 85. Nippon Shinyaku Musculoskeletal System Disorder Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Nippon Shinyaku Musculoskeletal System Disorder Drug Product Portfolio Table 87. Nippon Shinyaku Recent Development Table 88. Merck & Co Company Information Table 89. Merck & Co Business Overview Table 90. Merck & Co Musculoskeletal System Disorder Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Merck & Co Musculoskeletal System Disorder Drug Product Portfolio Table 92. Merck & Co Recent Development Table 93. GSK Company Information Table 94. GSK Business Overview Table 95. GSK Musculoskeletal System Disorder Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. GSK Musculoskeletal System Disorder Drug Product Portfolio Table 97. GSK Recent Development Table 98. Eisai Company Information Table 99. Eisai Business Overview Table 100. Eisai Musculoskeletal System Disorder Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Eisai Musculoskeletal System Disorder Drug Product Portfolio Table 102. Eisai Recent Development Table 103. Cadila Healthcare Company Information Table 104. Cadila Healthcare Business Overview Table 105. Cadila Healthcare Musculoskeletal System Disorder Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Cadila Healthcare Musculoskeletal System Disorder Drug Product Portfolio Table 107. Cadila Healthcare Recent Development Table 108. Bayer Company Information Table 109. Bayer Business Overview Table 110. Bayer Musculoskeletal System Disorder Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Bayer Musculoskeletal System Disorder Drug Product Portfolio Table 112. Bayer Recent Development Table 113. Astellas Pharma Company Information Table 114. Astellas Pharma Business Overview Table 115. Astellas Pharma Musculoskeletal System Disorder Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Astellas Pharma Musculoskeletal System Disorder Drug Product Portfolio Table 117. Astellas Pharma Recent Development Table 118. Asahi Kasei Company Information Table 119. Asahi Kasei Business Overview Table 120. Asahi Kasei Musculoskeletal System Disorder Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Asahi Kasei Musculoskeletal System Disorder Drug Product Portfolio Table 122. Asahi Kasei Recent Development Table 123. Amgen Company Information Table 124. Amgen Business Overview Table 125. Amgen Musculoskeletal System Disorder Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Amgen Musculoskeletal System Disorder Drug Product Portfolio Table 127. Amgen Recent Development Table 128. Abbott Company Information Table 129. Abbott Business Overview Table 130. Abbott Musculoskeletal System Disorder Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Abbott Musculoskeletal System Disorder Drug Product Portfolio Table 132. Abbott Recent Development Table 133. North America Musculoskeletal System Disorder Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. North America Musculoskeletal System Disorder Drug Market Size by Country (2021-2026) & (US$ Million) Table 135. North America Musculoskeletal System Disorder Drug Market Share by Country (2021-2026) Table 136. North America Musculoskeletal System Disorder Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. North America Musculoskeletal System Disorder Drug Market Share Forecast by Country (2027-2032) Table 138. Europe Musculoskeletal System Disorder Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Europe Musculoskeletal System Disorder Drug Market Size by Country (2021-2026) & (US$ Million) Table 140. Europe Musculoskeletal System Disorder Drug Market Share by Country (2021-2026) Table 141. Europe Musculoskeletal System Disorder Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Europe Musculoskeletal System Disorder Drug Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Musculoskeletal System Disorder Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Musculoskeletal System Disorder Drug Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Musculoskeletal System Disorder Drug Market Share by Country (2021-2026) Table 146. Asia-Pacific Musculoskeletal System Disorder Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Musculoskeletal System Disorder Drug Market Share Forecast by Country (2027-2032) Table 148. Latin America Musculoskeletal System Disorder Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Latin America Musculoskeletal System Disorder Drug Market Size by Country (2021-2026) & (US$ Million) Table 150. Latin America Musculoskeletal System Disorder Drug Market Share by Country (2021-2026) Table 151. Latin America Musculoskeletal System Disorder Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Latin America Musculoskeletal System Disorder Drug Market Share Forecast by Country (2027-2032) Table 153. Middle East & Africa Musculoskeletal System Disorder Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Middle East & Africa Musculoskeletal System Disorder Drug Market Size by Country (2021-2026) & (US$ Million) Table 155. Middle East & Africa Musculoskeletal System Disorder Drug Market Share by Country (2021-2026) Table 156. Middle East & Africa Musculoskeletal System Disorder Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Middle East & Africa Musculoskeletal System Disorder Drug Market Share Forecast by Country (2027-2032) Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Musculoskeletal System Disorder Drug Product Image Figure 3. Global Musculoskeletal System Disorder Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Musculoskeletal System Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 5. Global Musculoskeletal System Disorder Drug Market Share by Region: 2025 VS 2032 Figure 6. Global Musculoskeletal System Disorder Drug Market Share by Region (2021-2032) Figure 7. North America Musculoskeletal System Disorder Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Musculoskeletal System Disorder Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Musculoskeletal System Disorder Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Musculoskeletal System Disorder Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Musculoskeletal System Disorder Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Bone Disorder Image Figure 13. Global Bone Disorder Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Joint Disorder Image Figure 15. Global Joint Disorder Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Muscle Disorder Image Figure 17. Global Muscle Disorder Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Other Image Figure 19. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Musculoskeletal System Disorder Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Musculoskeletal System Disorder Drug Market Share by Type 2025 VS 2032 Figure 22. North America Musculoskeletal System Disorder Drug Market Size Share by Type (2021-2032) Figure 23. Europe Musculoskeletal System Disorder Drug Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Musculoskeletal System Disorder Drug Market Size Share by Type (2021-2032) Figure 25. Latin America Musculoskeletal System Disorder Drug Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Musculoskeletal System Disorder Drug Market Size Share by Type (2021-2032) Figure 27. Hospital & Clinic Image Figure 28. Global Hospital & Clinic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Retail Pharmacy Image Figure 30. Global Retail Pharmacy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Other Image Figure 32. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Musculoskeletal System Disorder Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Musculoskeletal System Disorder Drug Market Share by Application 2025 VS 2032 Figure 35. North America Musculoskeletal System Disorder Drug Market Size Share by Application (2021-2032) Figure 36. Europe Musculoskeletal System Disorder Drug Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Musculoskeletal System Disorder Drug Market Size Share by Application (2021-2032) Figure 38. Latin America Musculoskeletal System Disorder Drug Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Musculoskeletal System Disorder Drug Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Musculoskeletal System Disorder Drug Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Musculoskeletal System Disorder Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Musculoskeletal System Disorder Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Musculoskeletal System Disorder Drug Market Share by Country (2021-2032) Figure 45. Europe Musculoskeletal System Disorder Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Musculoskeletal System Disorder Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Musculoskeletal System Disorder Drug Market Share by Country (2021-2032) Figure 48. Asia-Pacific Musculoskeletal System Disorder Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Musculoskeletal System Disorder Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Musculoskeletal System Disorder Drug Market Share by Country (2021-2032) Figure 51. Latin America Musculoskeletal System Disorder Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Musculoskeletal System Disorder Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Musculoskeletal System Disorder Drug Market Share by Country (2021-2032) Figure 54. Middle East & Africa Musculoskeletal System Disorder Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Musculoskeletal System Disorder Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Musculoskeletal System Disorder Drug Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Bone Disorder
  • Joint Disorder
  • Muscle Disorder
  • Other
Applications
  • Hospital & Clinic
  • Retail Pharmacy
  • Other
Companies covered
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Eli Lilly
  • Pfizer
  • AbbVie
  • Torrent Pharmaceuticals
  • Nippon Shinyaku
  • Merck & Co
  • GSK
  • Eisai
  • Cadila Healthcare
  • Bayer
  • Astellas Pharma
  • Asahi Kasei
  • Amgen
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Musculoskeletal System Disorder Drug Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Musculoskeletal System Disorder Drug Market Size by Region (2021-2032)
  5. 1.4.1 Global Musculoskeletal System Disorder Drug Market Size by Region (2021-2026)
  6. 1.4.2 Global Musculoskeletal System Disorder Drug Market Size by Region (2027-2032)
  7. 1.5 Key Regions Musculoskeletal System Disorder Drug Market Size (2021-2032)
  8. 1.5.1 North America Musculoskeletal System Disorder Drug Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Musculoskeletal System Disorder Drug Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Musculoskeletal System Disorder Drug Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Musculoskeletal System Disorder Drug Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Musculoskeletal System Disorder Drug Market Size Growth Rate (2021-2032)
2 Musculoskeletal System Disorder Drug Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Bone Disorder
  3. 2.1.2 Joint Disorder
  4. 2.1.3 Muscle Disorder
  5. 2.1.4 Other
  6. 2.2 Global Musculoskeletal System Disorder Drug Market Size by Type
  7. 2.2.1 Global Musculoskeletal System Disorder Drug Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Musculoskeletal System Disorder Drug Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Musculoskeletal System Disorder Drug Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Musculoskeletal System Disorder Drug Market Size by Regions
  11. 2.3.1 North America Musculoskeletal System Disorder Drug Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Musculoskeletal System Disorder Drug Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Musculoskeletal System Disorder Drug Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Musculoskeletal System Disorder Drug Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Musculoskeletal System Disorder Drug Market Size Breakdown by Type (2021-2026)
3 Musculoskeletal System Disorder Drug Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital & Clinic
  3. 3.1.2 Retail Pharmacy
  4. 3.1.3 Other
  5. 3.2 Global Musculoskeletal System Disorder Drug Market Size by Application
  6. 3.2.1 Global Musculoskeletal System Disorder Drug Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Musculoskeletal System Disorder Drug Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Musculoskeletal System Disorder Drug Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Musculoskeletal System Disorder Drug Market Size by Regions
  10. 3.3.1 North America Musculoskeletal System Disorder Drug Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Musculoskeletal System Disorder Drug Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Musculoskeletal System Disorder Drug Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Musculoskeletal System Disorder Drug Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Musculoskeletal System Disorder Drug Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Musculoskeletal System Disorder Drug Industry Trends
  2. 4.2 Musculoskeletal System Disorder Drug Industry Drivers
  3. 4.3 Musculoskeletal System Disorder Drug Industry Opportunities and Challenges
  4. 4.4 Musculoskeletal System Disorder Drug Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Musculoskeletal System Disorder Drug Revenue (2021-2026)
  2. 5.2 Global Musculoskeletal System Disorder Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Musculoskeletal System Disorder Drug Key Company Headquarters & Area Served
  4. 5.4 Global Musculoskeletal System Disorder Drug Company, Product Type & Application
  5. 5.5 Global Musculoskeletal System Disorder Drug Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Musculoskeletal System Disorder Drug Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Musculoskeletal System Disorder Drug Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Musculoskeletal System Disorder Drug Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Musculoskeletal System Disorder Drug Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Musculoskeletal System Disorder Drug Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Johnson & Johnson
  8. 6.2.1 Johnson & Johnson Company Information
  9. 6.2.2 Johnson & Johnson Business Overview
  10. 6.2.3 Johnson & Johnson Musculoskeletal System Disorder Drug Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Johnson & Johnson Musculoskeletal System Disorder Drug Product Portfolio
  12. 6.2.5 Johnson & Johnson Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis Musculoskeletal System Disorder Drug Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Novartis Musculoskeletal System Disorder Drug Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Eli Lilly
  20. 6.4.1 Eli Lilly Company Information
  21. 6.4.2 Eli Lilly Business Overview
  22. 6.4.3 Eli Lilly Musculoskeletal System Disorder Drug Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Eli Lilly Musculoskeletal System Disorder Drug Product Portfolio
  24. 6.4.5 Eli Lilly Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer Musculoskeletal System Disorder Drug Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Pfizer Musculoskeletal System Disorder Drug Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 AbbVie
  32. 6.6.1 AbbVie Company Information
  33. 6.6.2 AbbVie Business Overview
  34. 6.6.3 AbbVie Musculoskeletal System Disorder Drug Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 AbbVie Musculoskeletal System Disorder Drug Product Portfolio
  36. 6.6.5 AbbVie Recent Developments
  37. 6.7 Torrent Pharmaceuticals
  38. 6.7.1 Torrent Pharmaceuticals Company Information
  39. 6.7.2 Torrent Pharmaceuticals Business Overview
  40. 6.7.3 Torrent Pharmaceuticals Musculoskeletal System Disorder Drug Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Torrent Pharmaceuticals Musculoskeletal System Disorder Drug Product Portfolio
  42. 6.7.5 Torrent Pharmaceuticals Recent Developments
  43. 6.8 Nippon Shinyaku
  44. 6.8.1 Nippon Shinyaku Company Information
  45. 6.8.2 Nippon Shinyaku Business Overview
  46. 6.8.3 Nippon Shinyaku Musculoskeletal System Disorder Drug Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Nippon Shinyaku Musculoskeletal System Disorder Drug Product Portfolio
  48. 6.8.5 Nippon Shinyaku Recent Developments
  49. 6.9 Merck & Co
  50. 6.9.1 Merck & Co Company Information
  51. 6.9.2 Merck & Co Business Overview
  52. 6.9.3 Merck & Co Musculoskeletal System Disorder Drug Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Merck & Co Musculoskeletal System Disorder Drug Product Portfolio
  54. 6.9.5 Merck & Co Recent Developments
  55. 6.10 GSK
  56. 6.10.1 GSK Company Information
  57. 6.10.2 GSK Business Overview
  58. 6.10.3 GSK Musculoskeletal System Disorder Drug Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 GSK Musculoskeletal System Disorder Drug Product Portfolio
  60. 6.10.5 GSK Recent Developments
  61. 6.11 Eisai
  62. 6.11.1 Eisai Company Information
  63. 6.11.2 Eisai Business Overview
  64. 6.11.3 Eisai Musculoskeletal System Disorder Drug Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Eisai Musculoskeletal System Disorder Drug Product Portfolio
  66. 6.11.5 Eisai Recent Developments
  67. 6.12 Cadila Healthcare
  68. 6.12.1 Cadila Healthcare Company Information
  69. 6.12.2 Cadila Healthcare Business Overview
  70. 6.12.3 Cadila Healthcare Musculoskeletal System Disorder Drug Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Cadila Healthcare Musculoskeletal System Disorder Drug Product Portfolio
  72. 6.12.5 Cadila Healthcare Recent Developments
  73. 6.13 Bayer
  74. 6.13.1 Bayer Company Information
  75. 6.13.2 Bayer Business Overview
  76. 6.13.3 Bayer Musculoskeletal System Disorder Drug Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Bayer Musculoskeletal System Disorder Drug Product Portfolio
  78. 6.13.5 Bayer Recent Developments
  79. 6.14 Astellas Pharma
  80. 6.14.1 Astellas Pharma Company Information
  81. 6.14.2 Astellas Pharma Business Overview
  82. 6.14.3 Astellas Pharma Musculoskeletal System Disorder Drug Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Astellas Pharma Musculoskeletal System Disorder Drug Product Portfolio
  84. 6.14.5 Astellas Pharma Recent Developments
  85. 6.15 Asahi Kasei
  86. 6.15.1 Asahi Kasei Company Information
  87. 6.15.2 Asahi Kasei Business Overview
  88. 6.15.3 Asahi Kasei Musculoskeletal System Disorder Drug Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Asahi Kasei Musculoskeletal System Disorder Drug Product Portfolio
  90. 6.15.5 Asahi Kasei Recent Developments
  91. 6.16 Amgen
  92. 6.16.1 Amgen Company Information
  93. 6.16.2 Amgen Business Overview
  94. 6.16.3 Amgen Musculoskeletal System Disorder Drug Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Amgen Musculoskeletal System Disorder Drug Product Portfolio
  96. 6.16.5 Amgen Recent Developments
  97. 6.17 Abbott
  98. 6.17.1 Abbott Company Information
  99. 6.17.2 Abbott Business Overview
  100. 6.17.3 Abbott Musculoskeletal System Disorder Drug Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Abbott Musculoskeletal System Disorder Drug Product Portfolio
  102. 6.17.5 Abbott Recent Developments
7 North America
  1. 7.1 North America Musculoskeletal System Disorder Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Musculoskeletal System Disorder Drug Market Size by Country (2021-2026)
  3. 7.3 North America Musculoskeletal System Disorder Drug Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Musculoskeletal System Disorder Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Musculoskeletal System Disorder Drug Market Size by Country (2021-2026)
  3. 8.3 Europe Musculoskeletal System Disorder Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Musculoskeletal System Disorder Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Musculoskeletal System Disorder Drug Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Musculoskeletal System Disorder Drug Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Musculoskeletal System Disorder Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Musculoskeletal System Disorder Drug Market Size by Country (2021-2026)
  3. 10.3 South America Musculoskeletal System Disorder Drug Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Musculoskeletal System Disorder Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Musculoskeletal System Disorder Drug Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Musculoskeletal System Disorder Drug Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst